The biological activities of CLA have been documented to have anti-atherogenic effects in an experimental model of atherosclerosis when administered in an 80:20 blend of its two most abundant isomers c9,t11-CLA and t10,c12-CLA, respectively (Toomey et al., 2006). The gene discussed is SELPLG; the disease is atherosclerosis.